| Geographic Distribution of Staphylococcus aureus Causing Invasive Infections in Europe: A Molecular-Epidemiological Analysis H Grundmann, DM Aanensen, CC Van Den Wijngaard, BG Spratt, ... PLoS medicine 7 (1), e1000215, 2010 | 648 | 2010 |
| An Outbreak of Infection due to β-Lactamase Klebsiella pneumoniae Carbapenemase 2–Producing K. pneumoniae in a Greek University Hospital: Molecular … M Souli, I Galani, A Antoniadou, E Papadomichelakis, G Poulakou, ... Clinical infectious diseases 50 (3), 364-373, 2010 | 438 | 2010 |
| Schizophrenia: a genome scan targets chromosomes 3p and 8p as potential sites of susceptibility genes AE Pulver, VK Lasseter, L Kasch, P Wolyniec, G Nestadt, JL Blouin, ... American journal of medical genetics 60 (3), 252-260, 1995 | 327 | 1995 |
| Whole-genome sequencing for routine pathogen surveillance in public health: a population snapshot of invasive Staphylococcus aureus in Europe DM Aanensen, EJ Feil, MTG Holden, J Dordel, CA Yeats, A Fedosejev, ... MBio 7 (3), 10.1128/mbio. 00444-16, 2016 | 213 | 2016 |
| Novel GES/IBC extended-spectrum β-lactamase variants with carbapenemase activity in clinical enterobacteria S Vourli, P Giakkoupi, V Miriagou, E Tzelepi, AC Vatopoulos, ... FEMS microbiology letters 234 (2), 209-231, 2006 | 144 | 2006 |
| Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals LNJ Falagas ME, Skalidis T, Vardakas KZ, HCS Group J Antimicrob Chemother. 72 (6), 1704-1708, 2017 | 110 | 2017 |
| Emergence of CTX-M-15-Producing Enterobacteria in Cameroon and Characterization of a blaCTX-M-15-Carrying Element J Gangoue-Pieboji, V Miriagou, S Vourli, E Tzelepi, P Ngassam, ... Antimicrobial agents and chemotherapy 49 (1), 441-443, 2005 | 80 | 2005 |
| Evaluation of two automated systems for colistin susceptibility testing of carbapenem-resistant Acinetobacter baumannii clinical isolates S Vourli, K Dafopoulou, G Vrioni, A Tsakris, S Pournaras Journal of Antimicrobial Chemotherapy 72 (9), 2528-2530, 2017 | 64 | 2017 |
| High rates of community-acquired, Panton-Valentine leukocidin (PVL)-positive methicillin-resistant S. aureus (MRSA) infections in adult outpatients in Greece S Vourli, H Vagiakou, G Ganteris, M Orfanidou, M Polemis, A Vatopoulos, ... Eurosurveillance 14 (2), 19089, 2009 | 64 | 2009 |
| Clinical and molecular epidemiology of community-acquired, methicillin-resistant Staphylococcus aureus infections in children in central Greece I Niniou, S Vourli, E Lebessi, M Foustoukou, A Vatopoulos, ... European Journal of Clinical Microbiology & Infectious Diseases 27, 831-837, 2008 | 52 | 2008 |
| Emergence of Proteus mirabilis carrying the blaVIM-1 metallo-β-lactamase gene S Vourli, H Tsorlini, H Katsifa, M Polemis, LS Tzouvelekis, A Kontodimou, ... Clinical microbiology and infection 12 (7), 691-694, 2006 | 50 | 2006 |
| COVID-19 and antimicrobial resistance: data from the Greek electronic system for the surveillance of antimicrobial resistance—WHONET-Greece (January 2018–March 2021) M Polemis, G Mandilara, O Pappa, A Argyropoulou, E Perivolioti, ... Life 11 (10), 996, 2021 | 46 | 2021 |
| Epidemiological trends of fungemia in Greece with a focus on candidemia during the recent financial crisis: A 10-year survey in a tertiary care academic hospital and review of … M Siopi, A Tarpatzi, E Kalogeropoulou, S Damianidou, A Vasilakopoulou, ... Antimicrobial agents and chemotherapy 64 (3), 10.1128/aac. 01516-19, 2020 | 45 | 2020 |
| Characterization of In111, a class 1 integron that carries the extended-spectrum β-lactamase gene blaIBC−1 S Vourli, LS Tzouvelekis, E Tzelepi, E Lebessi, NJ Legakis, V Miriagou FEMS microbiology letters 225 (1), 149-153, 2003 | 39 | 2003 |
| Community acquired MRSA infections in a paediatric population in Greece. VA Vourli S, Perimeni D, Makri A, Polemis M, Voyiatzi A Euro Surveill. 10 (5), 78-79, 2005 | 36* | 2005 |
| Transferable DHA-1 cephalosporinase in Escherichia coli P Giakkoupi, A Tambic-Andrasevic, S Vourli, J Skrlin, S Sestan-Crnek, ... International journal of antimicrobial agents 27 (1), 77-80, 2006 | 32 | 2006 |
| Activity of Sulbactam-Durlobactam and Comparators Against a National Collection of Carbapenem-Resistant Acinetobacter baumannii Isolates From Greece D Petropoulou, M Siopi, S Vourli, S Pournaras Frontiers in Cellular and Infection Microbiology 11, 814530, 2022 | 29 | 2022 |
| Exploring colistin pharmacodynamics against Klebsiella pneumoniae: a need to revise current susceptibility breakpoints M Tsala, S Vourli, PC Georgiou, S Pournaras, A Tsakris, GL Daikos, ... Journal of Antimicrobial Chemotherapy 73 (4), 953-961, 2018 | 29 | 2018 |
| Optimization of Polyene-Azole Combination Therapy against Aspergillosis Using an In Vitro Pharmacokinetic-Pharmacodynamic Model M Siopi, N Siafakas, S Vourli, L Zerva, J Meletiadis Antimicrobial Agents and Chemotherapy 59 (7), 3973-3983, 2015 | 29 | 2015 |
| Aminoglycoside-resistant staphylococci in Greece: prevalence and resistance mechanisms A Liakopoulos, A Foka, S Vourli, L Zerva, F Tsiapara, E Protonotariou, ... European journal of clinical microbiology & infectious diseases 30, 701-705, 2011 | 26 | 2011 |
